The Sri Lanka Pharmaceutical Manufacturers Association (SLPMA) issued a call to action urging all stakeholders within the local pharmaceutical industry to shape a future where Sri Lanka emerges as a trusted, high-quality, and export-driven pharmaceutical manufacturing hub.The

The Sri Lanka Pharmaceutical Manufacturers’ Association (SLPMA), in a historic step, issued a powerful national call to action urging all stakeholders to come together in a bold, unified effort to shape a future where Sri Lanka emerges

Warns domestic pharmaceutical production could collapse to 5% from current 25%Local manufacturers supply over 250 products, meeting 30 percent of government pharmaceutical needsStrengthening local pharmaceutical manufacturing “no longer an option” but “of national importance to ensure health

On July 11, 2025, SLPMA unveiled the “National Call to Produce Medicine in Sri Lanka—with Care, Trust, and Unity” at its AGM held at the Galle Face Hotel. The proposal presented:🔹 A strong national rationale🔹 A bold, future-ready